MedPath

Brain structure and neurocognitive development in sickle cell disease; a longitudinal cohort study (BRICK study)

Recruiting
Conditions
Sickle Cell Disease
10042258
10047075
Registration Number
NL-OMON51702
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
114
Inclusion Criteria

• Patients with sickle cell disease of all genotypes;

Exclusion Criteria

• Parents/ guardians (in case of minors) or patients themselves (>16 years)
unable to make an informed decision on participating in this study.
• An abnormal brain MRI prior to initiation of the study due to non-SCD related
causes.
• Contraindications for brain MRI per protocol

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>• Total white matter volume increase in children and adolescents with SCD</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>• Neurocognitive functioning (intelligence, specific neurocognitive functions,<br /><br>network organization)<br /><br>• Incidence of stroke<br /><br>• Other forms complications due to SCD<br /><br>• Amount of hospital admissions, day care admissions (adult care only), crises<br /><br>at home, contact moments with the sickle cell center, ER visits<br /><br>• Biomarkers for anemia, hemolysis, inflammation and endothelial activation.<br /><br>• Behavioral functioning</p><br>
© Copyright 2025. All Rights Reserved by MedPath